Cellular cellularAutophagy · target hub
ATG5 (ATG5)
ATG5 is a LC3 lipidation / lysosome on the Cellular autophagy signaling axis. Validate with UniProt and literature. Indexed under "ATG conjugation system" for antibodies and assay guidance.
| Type / example | Domain / context (brief) |
|---|---|
| Expression context | Tissue/cell-type–dependent expression |
| Rare variants | Sporadic variants—require validation |
| Pathway coupling | Co-occurs with neighboring nodes |
Naming and prevalence vary—annotate clinically with authoritative databases.
Examples below reflect common literature and public resources (e.g., CCLE, DepMap)—validate genotypes, expression, and passage in your own stocks before committing assays.
Human tissues and primary cells require ethics/IRB approval; tumors are heterogeneous—record histotype, site, and preservation conditions.
Overexpression vs endogenous ATG5 can differ in dosage, splicing, and compartmentation.
Adds ATG5 keyword bias atop the 细胞自噬信号通路 antibody pool—if sparse, use presets above or global search.
This content supports research reagents and pathway education—not medical advice. Annotate mutations, drug indications, and protocols with authoritative databases, datasheets, and institutional oversight.
Last reviewed: 2026-05-18
See the cellular cellularAutophagy hub for neighboring targets—cross-check PI3K, MAPK, and transmembrane transport pages as needed.